600671 天目药业
已收盘 08-31 15:00:00
资讯
新帖
简况
股市必读:天目药业中报 - 第二季度单季净利润同比下降51.76%
证券之星 · 08-31 05:54
股市必读:天目药业中报 - 第二季度单季净利润同比下降51.76%
每周股票复盘:天目药业(600671)Q2收入增7.14%
证券之星 · 08-30 04:36
每周股票复盘:天目药业(600671)Q2收入增7.14%
天目药业(600671)2026年中报简析:净利润同比下降38.5%
证券之星 · 08-29
天目药业(600671)2026年中报简析:净利润同比下降38.5%
天目药业(600671)7月20日股东户数0.9万户,较上期增加3.54%
证券之星 · 08-28
天目药业(600671)7月20日股东户数0.9万户,较上期增加3.54%
图解天目药业中报:第二季度单季净利润同比下降51.76%
证券之星 · 08-28
图解天目药业中报:第二季度单季净利润同比下降51.76%
天目药业(600671)披露2026年半年度报告,8月27日股价上涨0.1%
证券之星 · 08-27
天目药业(600671)披露2026年半年度报告,8月27日股价上涨0.1%
每周股票复盘:天目药业(600671)股东户数增3.89%,户均持股下降
证券之星 · 07-26
每周股票复盘:天目药业(600671)股东户数增3.89%,户均持股下降
天目药业(600671)披露控股股东拟协议转让20%股份事项,7月23日股价下跌6.23%
证券之星 · 07-23
天目药业(600671)披露控股股东拟协议转让20%股份事项,7月23日股价下跌6.23%
天目药业(600671)7月20日股东户数0.9万户,较上期增加3.89%
证券之星 · 07-22
天目药业(600671)7月20日股东户数0.9万户,较上期增加3.89%
每周股票复盘:天目药业(600671)控股股东拟转让20%股份或致实控权变更
证券之星 · 07-19
每周股票复盘:天目药业(600671)控股股东拟转让20%股份或致实控权变更
股市必读:天目药业(600671)7月14日收盘跌7.48%,主力净流入1285.75万元
证券之星 · 07-15
股市必读:天目药业(600671)7月14日收盘跌7.48%,主力净流入1285.75万元
天目药业最新公告:控股股东拟公开征集转让20%股份可能导致公司控制权变更
证券之星 · 07-13
天目药业最新公告:控股股东拟公开征集转让20%股份可能导致公司控制权变更
异动快报:天目药业(600671)7月13日9点49分触及涨停板
证券之星 · 07-13
异动快报:天目药业(600671)7月13日9点49分触及涨停板
天目药业:反弹收涨 4.61%,单季利润回落
E药资本界 · 07-09
天目药业:反弹收涨 4.61%,单季利润回落
每周股票复盘:天目药业(600671)召开2026年第一次临时股东会
证券之星 · 07-05
每周股票复盘:天目药业(600671)召开2026年第一次临时股东会
天目药业(600671)披露2026年第一次临时股东会决议公告,6月29日股价下跌2.92%
证券之星 · 06-29
天目药业(600671)披露2026年第一次临时股东会决议公告,6月29日股价下跌2.92%
股市必读:天目药业(600671)6月24日收盘跌6.11%,主力净流出354.48万元
证券之星 · 06-25
股市必读:天目药业(600671)6月24日收盘跌6.11%,主力净流出354.48万元
股市必读:天目药业6月18日涨停收盘,收盘价17.96元
证券之星 · 06-22
股市必读:天目药业6月18日涨停收盘,收盘价17.96元
每周股票复盘:天目药业(600671)保健品收入增33.50%,毛利率达82.99%
证券之星 · 06-20
每周股票复盘:天目药业(600671)保健品收入增33.50%,毛利率达82.99%
天目药业(600671)披露2026年第一次临时股东会会议资料,6月18日股价上涨9.98%
证券之星 · 06-18
天目药业(600671)披露2026年第一次临时股东会会议资料,6月18日股价上涨9.98%
加载更多
公司概况
公司名称:
杭州天目山药业股份有限公司
所属行业:
医药制造业
上市日期:
1993-08-23
主营业务:
杭州天目山药业股份有限公司的主营业务是医药产品研发、生产与销售。公司的主要产品是六味地黄口服液、河车大造胶囊、养阴清肺糖浆、安眠补脑颗粒。公司拥有“天目山”“黄山”“新安江”等驰名商标,已分别在杭州和黄山建成三个符合GMP标准的化药、中成药及原料药生产基地,核心产品六味地黄口服液、薄荷脑、铁皮石斛系列保健品在市场上享有一定的美誉度、拥有一批忠实的消费者,公司在医药健康领域具有一定的影响力。
发行价格:
1.00
{"stockData":{"symbol":"600671","market":"SH","secType":"STK","nameCN":"天目药业","latestPrice":22.86,"timestamp":1788159600000,"preClose":20.78,"halted":0,"volume":10785964,"delay":0,"changeRate":0.1001,"floatShares":122000000,"shares":122000000,"eps":0.1124,"marketStatus":"已收盘","change":2.08,"latestTime":"08-31 15:00:00","open":20.14,"high":22.86,"low":20.14,"amount":240000000,"amplitude":0.1309,"askPrice":0,"askSize":0,"bidPrice":22.86,"bidSize":15171,"shortable":0,"etf":0,"ttmEps":0.1124,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.78,"symbolType":"stock","openAndCloseTimeList":[[1788139800000,1788147000000],[1788152400000,1788159600000]],"highLimit":22.86,"lowLimit":18.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":121778885,"isCdr":false,"pbRate":36.48,"roa":"--","peRate":203.380783,"roe":"8.6146%","epsLYR":0.1447,"committee":0,"marketValue":2784000000,"turnoverRate":0.0886,"status":0,"floatMarketCap":2784000000},"requestUrl":"/m/hq/s/600671","defaultTab":"news","newsList":[{"id":"2663047418","title":"股市必读:天目药业中报 - 第二季度单季净利润同比下降51.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047418","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047418?lang=zh_cn&edition=full","pubTime":"2026-08-31 05:54","pubTimestamp":1788126855,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年第二季度单季度归母净利润248.61万元,同比下降51.76%。业绩披露要点财务报告2026年中报显示:上半年主营收入9935.47万元,同比下降4.1%;归母净利润630.22万元,同比下降38.5%;扣非净利润232.09万元,同比下降60.68%;第二季度单季度主营收入5496.61万元,同比上升7.14%;单季度归母净利润248.61万元,同比下降51.76%;单季度扣非净利润5.57万元,同比下降97.52%;负债率78.12%,财务费用336.22万元,毛利率50.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001006","title":"每周股票复盘:天目药业(600671)Q2收入增7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663001006?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:36","pubTimestamp":1788035772,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,天目药业报收于20.78元,较上周的20.51元上涨1.32%。本周,天目药业8月28日盘中最高价报21.16元。股本股东变化股东户数变动截至2026年7月20日,公司股东户数为8999.0户,较6月30日增加308.0户,增幅3.54%。公司公告汇总杭州天目山药业股份有限公司2026年半年度报告摘要截至报告期末,公司总资产为452,071,424.48元,较上年度末增长2.27%;归属于上市公司股东的净资产为76,308,718.29元,较上年度末增长9.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","600671","BK0174","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016302","title":"天目药业(600671)2026年中报简析:净利润同比下降38.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016302?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:04","pubTimestamp":1787954652,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期天目药业发布2026年中报。根据财报显示,天目药业净利润同比下降38.5%。截至本报告期末,公司营业总收入9935.47万元,同比下降4.1%,归母净利润630.22万元,同比下降38.5%。按单季度数据看,第二季度营业总收入5496.61万元,同比上升7.14%,第二季度归母净利润248.61万元,同比下降51.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900010386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065178","title":"天目药业(600671)7月20日股东户数0.9万户,较上期增加3.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065178","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662065178?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:36","pubTimestamp":1787909786,"startTime":"0","endTime":"0","summary":"证券之星消息,近日天目药业披露,截至2026年7月20日公司股东户数为8999.0户,较6月30日增加308.0户,增幅为3.54%。在中药行业个股中,天目药业股东户数低于行业平均水平,截至7月20日,中药行业平均股东户数为5.16万户。从股价来看,2026年6月30日至2026年7月20日,天目药业区间涨幅为19.25%,在此期间股东户数增加308.0户,增幅为3.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0174","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662822440","title":"图解天目药业中报:第二季度单季净利润同比下降51.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662822440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662822440?lang=zh_cn&edition=full","pubTime":"2026-08-28 01:46","pubTimestamp":1787852804,"startTime":"0","endTime":"0","summary":"证券之星消息,天目药业2026年中报显示,上半年度公司主营收入9935.47万元,同比下降4.1%;归母净利润630.22万元,同比下降38.5%;扣非净利润232.09万元,同比下降60.68%;其中2026年第二季度,公司单季度主营收入5496.61万元,同比上升7.14%;单季度归母净利润248.61万元,同比下降51.76%;单季度扣非净利润5.57万元,同比下降97.52%;负债率78.12%,投资收益-0.56万元,财务费用336.22万元,毛利率50.38%。财报数据概要请见下图:本文数据来源于天目药业2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800004882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086868","title":"天目药业(600671)披露2026年半年度报告,8月27日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662086868?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:28","pubTimestamp":1787840935,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘,天目药业报收于20.2元,较前一交易日上涨0.1%,最新总市值为24.6亿元。该股当日开盘20.18元,最高20.35元,最低19.97元,成交额达2673.42万元,换手率为1.09%。近日,杭州天目山药业股份有限公司披露《2026年半年度报告》。公告显示,截至报告期末,公司总资产为452,071,424.48元,较上年度末增长2.27%;归属于上市公司股东的净资产为76,308,718.29元,较上年度末增长9.00%。加权平均净资产收益率为8.6146%,较上年同期减少9.02个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0174","600671","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654573190","title":"每周股票复盘:天目药业(600671)股东户数增3.89%,户均持股下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2654573190","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654573190?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:21","pubTimestamp":1785003669,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,天目药业报收于19.33元,较上周的20.77元下跌6.93%。本周,天目药业7月22日盘中最高价报21.87元。天目药业当前最新总市值23.54亿元,在中药板块市值排名57/66,在两市A股市值排名4528/5200。股本股东变化股东户数变动截至2026年7月20日,公司股东户数为8999.0户,较6月10日增加337.0户,增幅为3.89%。户均持股数量由上期的1.41万股减少至1.35万股,户均持股市值为27.24万元。本次转让可能导致公司控股股东及实际控制人变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","600671","BK0174","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774558","title":"天目药业(600671)披露控股股东拟协议转让20%股份事项,7月23日股价下跌6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774558","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653774558?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:50","pubTimestamp":1784800249,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘,天目药业报收于20.18元,较前一交易日下跌6.23%,最新总市值为24.57亿元。该股当日开盘21.52元,最高21.58元,最低19.72元,成交额达1.51亿元,换手率为6.03%。近日,杭州天目山药业股份有限公司发布《关于控股股东拟通过公开征集转让方式协议转让公司部分股份公开征集受让方的公告》。意向受让方需在2026年8月5日17:30前提交申请材料,并缴纳不低于转让总价款30%的缔约保证金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300036525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0174","BK0239","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653664756","title":"天目药业(600671)7月20日股东户数0.9万户,较上期增加3.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653664756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653664756?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:43","pubTimestamp":1784713385,"startTime":"0","endTime":"0","summary":"证券之星消息,近日天目药业披露,截至2026年7月20日公司股东户数为8999.0户,较6月10日增加337.0户,增幅为3.89%。在中药行业个股中,天目药业股东户数低于行业平均水平,截至7月20日,中药行业平均股东户数为5.36万户。从股价来看,2026年6月10日至2026年7月20日,天目药业区间涨幅为23.8%,在此期间股东户数增加337.0户,增幅为3.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0239","BK0174","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652304882","title":"每周股票复盘:天目药业(600671)控股股东拟转让20%股份或致实控权变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2652304882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652304882?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:44","pubTimestamp":1784400250,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,天目药业报收于20.77元,较上周的19.21元上涨8.12%。本周,天目药业7月17日盘中最高价报21.99元。本周关注点公司公告汇总:控股股东拟转让20%股份,可能导致控制权变更公司公告汇总杭州天目山药业股份有限公司控股股东青岛汇隆华泽投资有限公司持有公司股份36,519,460股,占公司总股本的29.99%。本次转让可能导致公司控股股东及实际控制人发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","BK0086","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651098488","title":"股市必读:天目药业(600671)7月14日收盘跌7.48%,主力净流入1285.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651098488","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651098488?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:27","pubTimestamp":1784050030,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,天目药业报收于19.55元,下跌7.48%,换手率10.27%,成交量12.5万手,成交额2.48亿元。交易信息汇总股价提醒7月14日天目药业收盘报19.55元,跌7.48%,当日成交2.48亿元。前10个交易日资金流向情况:主力资金累计净流入3090.65万元,股价累计下跌7.48%。汇隆华泽拟通过公开征集受让方的方式协议转让所持公司部分股份24,355,777股,占公司总股本的20%。转让完成后,汇隆华泽持股比例降至9.99%。本次转让可能导致公司控股股东及实际控制人发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500001919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0174","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711243","title":"天目药业最新公告:控股股东拟公开征集转让20%股份可能导致公司控制权变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651711243?lang=zh_cn&edition=full","pubTime":"2026-07-13 21:40","pubTimestamp":1783950022,"startTime":"0","endTime":"0","summary":"天目药业(600671.SH)公告称,公司控股股东汇隆华泽拟通过公开征集受让方的方式协议转让公司部分股份24,355,777股,占公司总股本的20%。转让完成后,汇隆华泽持股比例降至9.99%。该事项可能导致公司控股股东及实际控制人发生变更。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300039015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0086","BK0239","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162158","title":"异动快报:天目药业(600671)7月13日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651162158?lang=zh_cn&edition=full","pubTime":"2026-07-13 09:50","pubTimestamp":1783907435,"startTime":"0","endTime":"0","summary":"证券之星7月13日盘中消息,9点49分天目药业(600671)触及涨停板。其所属行业中药目前上涨。领涨股为陇神戎发。该股为保健品,中药,眼科概念热股,当日保健品概念上涨1.82%,中药概念上涨0.9%,眼科概念上涨0.29%。7月10日的资金流向数据方面,主力资金净流出57.63万元,占总成交额0.89%,游资资金净流入55.71万元,占总成交额0.86%,散户资金净流入1.92万元,占总成交额0.03%。近5日资金流向一览见下表:天目药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300004927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0174","BK0239","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650929637","title":"天目药业:反弹收涨 4.61%,单季利润回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2650929637","media":"E药资本界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650929637?lang=zh_cn&edition=full","pubTime":"2026-07-09 18:08","pubTimestamp":1783591680,"startTime":"0","endTime":"0","summary":"截至发稿,天目药业收盘价 19.29 元,涨幅 4.61%,成交额 8564.61 万元,换手率 3.70%,量比 1.13,日内振幅 9.49%;股价前期高点 23.44 元回落,阶段低点 15.70 元筑底后开启反弹修复行情。基本面数据2025 年:营收 2.12 亿元,同比小幅下滑 2.55%;归母净利润 1762 万元,同比上涨 15.6%,营收小幅收缩,盈利实现小幅抬升。2026 年一季度:归母净利润 382 万元,同比下滑 25.09%,单季度盈利有所回落。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-09/doc-inihfayz8621303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0174","600671","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649921366","title":"每周股票复盘:天目药业(600671)召开2026年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2649921366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649921366?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:04","pubTimestamp":1783195453,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,天目药业报收于18.46元,较上周的17.12元上涨7.83%。本周,天目药业7月3日盘中最高价报18.77元。本周关注点公司公告汇总:天目药业召开2026年第一次临时股东会,审议通过董事薪酬相关议案。公司公告汇总杭州天目山药业股份有限公司于2026年6月29日召开2026年第一次临时股东会,会议由董事长刘加勇主持,采用现场与网络投票结合方式召开。出席会议股东共42人,代表有表决权股份53,956,787股,占公司总股本的44.3071%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0174","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370495","title":"天目药业(600671)披露2026年第一次临时股东会决议公告,6月29日股价下跌2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647370495?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:34","pubTimestamp":1782743660,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,天目药业报收于16.62元,较前一交易日下跌2.92%,最新总市值为20.24亿元。近日,天目药业披露《2026年第一次临时股东会决议公告》。公告显示,公司于2026年6月29日召开2026年第一次临时股东会,会议由董事长刘加勇主持,采用现场与网络投票结合方式召开。出席会议股东共42人,代表有表决权股份53,956,787股,占公司总股本的44.3071%。上海泽昌律师事务所对本次会议出具法律意见,认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0174","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646843832","title":"股市必读:天目药业(600671)6月24日收盘跌6.11%,主力净流出354.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646843832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646843832?lang=zh_cn&edition=full","pubTime":"2026-06-25 03:23","pubTimestamp":1782328991,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,天目药业报收于16.75元,下跌6.11%,换手率3.96%,成交量4.82万手,成交额8116.89万元。交易信息汇总股价提醒6月24日天目药业收盘报16.75元,跌6.11%,当日成交8116.89万元。资金流向6月24日主力资金净流出354.48万元,占总成交额0.0%;游资资金净流入304.73万元,占总成交额0.0%;散户资金净流入49.75万元,占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500003369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","600671","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645015801","title":"股市必读:天目药业6月18日涨停收盘,收盘价17.96元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645015801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645015801?lang=zh_cn&edition=full","pubTime":"2026-06-22 02:36","pubTimestamp":1782066973,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,天目药业报收于17.96元,上涨9.98%,涨停,换手率5.84%,成交量7.11万手,成交额1.23亿元。交易信息汇总股价提醒天目药业6月18日涨停收盘,收盘价17.96元;该股于14点4分涨停,盘中2次打开涨停,收盘封单资金571.67万元,占其流通市值0.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0174","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644063975","title":"每周股票复盘:天目药业(600671)保健品收入增33.50%,毛利率达82.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644063975","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644063975?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:13","pubTimestamp":1781892789,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,天目药业报收于17.96元,较上周的16.47元上涨9.05%。本周,天目药业6月18日盘中最高价报17.96元。尤尼泰振青会计师事务所就杭州天目山药业股份有限公司2025年年度报告的信息披露问询函作出回复,涵盖收入及毛利率、应收账款、资产减值等问题。公司2025年实现营业收入2.12亿元,同比下降2.55%,扣非前后净利润同比增长15.59%和35.19%。保健品业务收入增长33.50%,毛利率达82.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0174","600671"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084853","title":"天目药业(600671)披露2026年第一次临时股东会会议资料,6月18日股价上涨9.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644084853?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:26","pubTimestamp":1781792779,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,天目药业报收于17.96元,较前一交易日上涨9.98%,最新总市值为21.87亿元。该股当日开盘16.33元,最高17.96元,最低15.87元,成交额达1.23亿元,换手率为5.84%。近日,杭州天目山药业股份有限公司发布2026年第一次临时股东会会议资料。公告显示,公司拟召开2026年第一次临时股东会,审议修订《董事和高级管理人员薪酬管理制度》及2026年度董事薪酬方案。相关议案已获董事会及薪酬与考核委员会通过,需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600671","BK0086","BK0174"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788216457333,"stockEarnings":[{"period":"1week","weight":0.1522},{"period":"1month","weight":0.1261},{"period":"3month","weight":0.3123},{"period":"6month","weight":0.1239},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.3206}],"compareEarnings":[{"period":"1week","weight":0.0269},{"period":"1month","weight":0.0402},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0236},{"period":"1year","weight":0.0333},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州天目山药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8999人(较上一季度增加3.54%)","perCapita":"13531股","listingDate":"1993-08-23","address":"浙江省杭州市临安区锦南街道上杨路18号","registeredCapital":"12177万元","survey":" 杭州天目山药业股份有限公司的主营业务是医药产品研发、生产与销售。公司的主要产品是六味地黄口服液、河车大造胶囊、养阴清肺糖浆、安眠补脑颗粒。公司拥有“天目山”“黄山”“新安江”等驰名商标,已分别在杭州和黄山建成三个符合GMP标准的化药、中成药及原料药生产基地,核心产品六味地黄口服液、薄荷脑、铁皮石斛系列保健品在市场上享有一定的美誉度、拥有一批忠实的消费者,公司在医药健康领域具有一定的影响力。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天目药业(600671)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天目药业(600671)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天目药业,600671,天目药业股票,天目药业股票老虎,天目药业股票老虎国际,天目药业行情,天目药业股票行情,天目药业股价,天目药业股市,天目药业股票价格,天目药业股票交易,天目药业股票购买,天目药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天目药业(600671)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天目药业(600671)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}